SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001513160-12-000046
Filing Date
2012-07-06
Accepted
2012-07-06 17:14:37
Documents
2
Period of Report
2012-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT genesis8k063012.htm 8-K 21922
2 FORM OF MATURITY DATE EXTENSION ex101.htm EX-10.1 11665
  Complete submission text file 0001513160-12-000046.txt   34826
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 12951255
SIC: 4731 Arrangement of Transportation of Freight & Cargo